Cutting-Edge Science and Innovation

REVOLUTIONIZING FERTILITY
& REPRODUCTIVE HEALTH

Making reproductive health solutions more accessible, effective, and affordable for individuals and families on their fertility journey.

A First-in-Class Fertility Discovery

Aqua Fem, LLC is offering the IP rights to AF — a proprietary compound that increases human sperm motility by over 700% on contact. Backed by strong preclinical data and protected by international patents, AF represents a scalable solution to a critical and underserved need in a $38B global fertility market.

Learn More

Download the AF Overview

MEET OUR TEAM

Leaders in Fertility and Groundbreaking Science

Aqua Fem’s founding team brings deep expertise in reproductive science, regulatory strategy, biotech commercialization, and consumer health. They are advancing solutions that expand access and improve outcomes in fertility care.

Learn More

INSIGHTS & THOUGHT LEADERSHIP

Science, Strategy, and What’s Next in Fertility

From investor readiness to male reproductive health, explore timely insights from Aqua Fem's leadership.

Read The Articles

Making the Science Stick: Communicating Complex Biotech Ideas for Any Audience

Learn how to simplify complex biotech concepts without losing accuracy. Discover strategies for science communication that resonate with investors, regulators, partners, and the public — with practical storytelling, analogies, and visuals.

The Untapped Potential of Male Fertility Testing in Preventive Healthcare

Sperm health is more than fertility. Learn why male fertility testing should be part of preventive healthcare and annual men’s checkups.

From Bench to Benefit: Translating Science into Real-World Impact

Discover how translational science bridges the gap between biotech innovation and real-world healthcare impact. Learn why usability, scalability, and equity are essential for bringing fertility treatment innovations—like Aqua Fem’s AF compound—successfully from lab to life.

PATENT-PROTECTED IP ASSET READY FOR ACQUISITION

Fertility IP for Sale | Novel Sperm Motility Compound

LETS TALK

Ready to Learn More?

We’re actively seeking a strategic acquirer to bring AF to market. Download the overview or reach out to schedule an introductory call.